HBM's (HKG:2142) chief executive officer and chairman, Jingsong Wang, bought an additional 400,000 shares in the company from the open market at HK$3.5 apiece on Jan. 27, a Jan. 28 Hong Kong bourse filing stated.
The shares represent roughly 0.052% of the drugmaker's issued share capital.
Following the purchase, Wang holds 70,297,400, or 9.212%, shares in the company.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。